热门资讯> 正文

DXC Technology定价6.5亿欧元高级票据

2025-12-03 06:16

DXC Technology(DXC) 0
Crescent Biopharma(CBIO) 0

DXC Technology (NYSE:DXC) announced on Tuesday that its wholly owned subsidiary, DXC Capital Funding DAC, priced an offering of €650M of its 4.250% senior notes due 2030.
The offering will be priced at 99.784% of the aggregate principal amount of such notes.
The offering of the notes is expected to close on December 9, 2025, subject to customary conditions.
The company intends to apply the net proceeds from the offering to repay its existing debt, including the company's 1.750% senior notes due 2026, and for working capital and general corporate purposes.

More on DXC Technology Company

DXC Technology Company (DXC) Presents at J.P. Morgan 2025 Ultimate Services Investor Conference Transcript
The Bottom Fishing Club - DXC Technology: Exceptional FCF Yield And AI Catalysts
DXC Technology Company 2026 Q2 - Results - Earnings Call Presentation
DXC targets doubling SAP and SaaS revenue over next 2-3 years while advancing AI-driven fast track solutions
DXC Technology Company Non-GAAP EPS of $0.84 beats by $0.14, revenue of $3.16B misses by $10M

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。